Compare Honeywell International Inc (HON) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Honeywell International Inc vs 22nd Century Group Inc — how do they compare? Honeywell International Inc trades at $207.73 (market cap $65.48B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Honeywell International Inc is far larger — about 105329.2× 22nd Century Group Inc's market cap, and Honeywell International Inc pays a 1.36% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Honeywell International Inc for 91 Days and 22nd Century Group Inc for 32 Days on average.
| HON | XXII | |
|---|---|---|
Market Cap | $65.48B | $621.67K |
Volume | 2,047,782 | 45,625 |
Sector | Industrials | Consumer Staples |
52-Week High | $248.79 | $483.00 |
52-Week Low | $188.14 | $0.80 |
Typical Hold Time | 91 Days | 32 Days |
Enterprise Value | $90.27B | -$3.69M |
Dividend Yield | 1.36% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Honeywell International (HON) trades at $206.6, down 0.73% on the day, with technical indicators showing a bearish trend while maintaining strong fundamental metrics including a low P/E of 7.94 and robust ROE of 47.43%. The company recently secured a $300 million refinery project with Dangote and completed its transformation into a pure-play automation business following corporate spinoffs. Recent quarterly earnings have consistently exceeded expectations, with Q2 2026 EPS of $1.95 beating estimates of $1.80.
Wall Street maintains strong bullish sentiment with 20 buy ratings and a $259.25 consensus price target representing 25% upside potential. Key risks include increasing debt-to-asset ratios (47.66% in 2025) and potential execution challenges in the post-spinoff transition. The company's focused automation strategy and strong profitability metrics support long-term growth prospects despite near-term technical weakness.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Honeywell International Inc
Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
